IL10 and type 2 diabetes mellitus: Kowalski et al. used bone marrow transfer techniques to create hematopoietic-cell restricted deletion of IL10 in mice and reported no impact of IL10 deletion on HFD-induced inflammation or insulin resistance, arguing against a role for IL10 in T2D-related pathology36.